Technical Analysis for CDT - Conduit Pharmaceuticals Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.00 | -6.12% | -0.06 |
CDT closed down 6.12 percent on Monday, July 1, 2024, on 1.37 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | -6.12% | |
| Pocket Pivot | Bullish Swing Setup | -6.12% | |
| Volume Surge | Other | -6.12% | |
| Doji - Bullish? | Reversal | -6.12% |
| Alert | Time |
|---|---|
| Down 5% | about 5 hours ago |
| Down 3% | about 5 hours ago |
| Down 2 % | about 5 hours ago |
| Down 1% | about 5 hours ago |
| Possible NR7 | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
Sector: Healthcare
Industry: Biotechnology
Keywords: Autoimmune Disease Tax Investigation Stage Specialty Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Autoimmune Disease Tax Investigation Stage Specialty Biopharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.0 |
| 52 Week Low | 0.63 |
| Average Volume | 112,185 |
| 200-Day Moving Average | 3.45 |
| 50-Day Moving Average | 2.60 |
| 20-Day Moving Average | 1.95 |
| 10-Day Moving Average | 1.31 |
| Average True Range | 0.31 |
| RSI (14) | 16.67 |
| ADX | 31.36 |
| +DI | 7.39 |
| -DI | 32.14 |
| Chandelier Exit (Long, 3 ATRs) | 2.22 |
| Chandelier Exit (Short, 3 ATRs) | 1.55 |
| Upper Bollinger Bands | 3.40 |
| Lower Bollinger Band | 0.50 |
| Percent B (%b) | 0.17 |
| BandWidth | 148.40 |
| MACD Line | -0.50 |
| MACD Signal Line | -0.41 |
| MACD Histogram | -0.0838 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.17 | ||||
| Resistance 3 (R3) | 1.17 | 1.10 | 1.14 | ||
| Resistance 2 (R2) | 1.10 | 1.06 | 1.11 | 1.13 | |
| Resistance 1 (R1) | 1.05 | 1.03 | 1.02 | 1.05 | 1.12 |
| Pivot Point | 0.99 | 0.99 | 0.97 | 0.99 | 0.99 |
| Support 1 (S1) | 0.93 | 0.94 | 0.90 | 0.94 | 0.87 |
| Support 2 (S2) | 0.87 | 0.91 | 0.87 | 0.86 | |
| Support 3 (S3) | 0.82 | 0.87 | 0.85 | ||
| Support 4 (S4) | 0.82 |
